Emilia Loch
Research Subjects
Emilia Loch has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Kamil Kerknawi
Zagłębie Oncology Center in Dąbrowa Górnicza, Poland
2 shared publications - Paulina Mikulec
Zagłębie Oncology Center in Dąbrowa Górnicza, Dąbrowa Górnicza, Poland
2 shared publications - Adrianna Truszyńska-Zawisza
The Military Institute of Aviation Medicine, Warsaw, Poland
1 shared publication - Aleksandra Białas
Military Institute of Medicine in Warsaw, Warsaw, Poland
1 shared publication - Aleksandra Młocek
Military Institute of Medicine in Warsaw, Warsaw, Poland
1 shared publication - Karolina Gorczyca
Military Institute of Medicine in Warsaw, Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
PREMENSTRUAL SYNDROME (PMS) – A REVIEW OF PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT APPROACHES
Premenstrual Syndrome (PMS) and its severe form, Premenstrual Dysphoric Disorder (PMDD), are prevalent cyclical disorders affecting the emotional, behavioral, and physical well-being of women of reproductive age. This review aims to present an overview of the current understanding of PMS/PMDD and critically examine both pharmacological and non-pharmacological treatment methods. Based on recent clinical trials and systematic reviews, selective serotonin reuptake inhibitors (SSRIs), hormonal therapies, and emerging drugs like sepranolone and ulipristal acetate demonstrate efficacy in symptom reduction (Bäckström et al., 2021; Comasco et al., 2020; Maranho et al., 2023). Simultaneously, cognitive-behavioral therapy (CBT), mindfulness-based interventions, nutritional supplements, herbal medicine, and even open-label placebos are gaining attention as effective non-pharmacological alternatives (Frey Nascimento et al., 2025; Reilly et al., 2023; Shojiasi et al., 2024; Sultana et al., 2022). Despite promising findings, further high-quality research is needed to tailor personalized and integrative treatment strategies.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
Open AccessPREMENSTRUAL SYNDROME (PMS) – A REVIEW OF PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT APPROACHES
Premenstrual Syndrome (PMS) and its severe form, Premenstrual Dysphoric Disorder (PMDD), are prevalent cyclical disorders affecting the emotional, behavioral, and physical well-being of women of reproductive age. This review aims to present an overview of the current understanding of PMS/PMDD and critically examine both pharmacological and non-pharmacological treatment methods. Based on recent clinical trials and systematic reviews, selective serotonin reuptake inhibitors (SSRIs), hormonal therapies, and emerging drugs like sepranolone and ulipristal acetate demonstrate efficacy in symptom reduction (Bäckström et al., 2021; Comasco et al., 2020; Maranho et al., 2023). Simultaneously, cognitive-behavioral therapy (CBT), mindfulness-based interventions, nutritional supplements, herbal medicine, and even open-label placebos are gaining attention as effective non-pharmacological alternatives (Frey Nascimento et al., 2025; Reilly et al., 2023; Shojiasi et al., 2024; Sultana et al., 2022). Despite promising findings, further high-quality research is needed to tailor personalized and integrative treatment strategies.
- Open Access
- 23 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(47))
THE MULTIDIMENSIONAL IMPACT OF HIGH-INTENSITY INTERVAL TRAINING (HIIT) ON GLYCEMIC CONTROL, CARDIORESPIRATORY FITNESS, BODY COMPOSITION, AND METABOLIC AND INFLAMMATORY MARKERS IN PATIENTS WITH TYPE 2 DIABETES: A REVIEW OF EVIDENCE AND CLINICAL IMPLICATION
Introduction: Type 2 Diabetes Mellitus (T2DM) is a major global health burden, marked by chronic hyperglycemia and complications. Physical activity is central to management, with High-Intensity Interval Training (HIIT) emerging as a time-efficient, evidence-based approach. This review examines HIIT’s impact on glycemic control, cardiorespiratory fitness, body composition, and inflammation, also addressing safety and feasibility. Methods: A narrative review was conducted via PubMed using terms such as”Type 2 Diabetes, "“glycemia, "“HbA1c, "“physical activity, " and”HIIT." From forty articles screened, nineteen met inclusion criteria. Results and Discussion: HIIT effectively improves T2DM outcomes. It lowers HbA1c, fasting and postprandial glucose, and enhances insulin sensitivity and beta-cell function. Compared to moderate-intensity continuous training (MICT), HIIT often yields superior VO₂max improvements. It also reduces BMI, total and visceral fat, and improves lipid profiles. HIIT is associated with lower inflammatory markers. Implementation is feasible and safe, even for older adults, with high adherence and minimal adverse events. Conclusion: HIIT is a potent non-pharmacological tool in T2DM management, offering benefits across metabolic and cardiovascular domains. Its ability to improve glycemic control, fitness, body composition, and inflammation underscores its clinical relevance. Current evidence supports integrating HIIT into standard care for T2DM patients.
- 23 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(47))
Open AccessTHE MULTIDIMENSIONAL IMPACT OF HIGH-INTENSITY INTERVAL TRAINING (HIIT) ON GLYCEMIC CONTROL, CARDIORESPIRATORY FITNESS, BODY COMPOSITION, AND METABOLIC AND INFLAMMATORY MARKERS IN PATIENTS WITH TYPE 2 DIABETES: A REVIEW OF EVIDENCE AND CLINICAL IMPLICATION
Introduction: Type 2 Diabetes Mellitus (T2DM) is a major global health burden, marked by chronic hyperglycemia and complications. Physical activity is central to management, with High-Intensity Interval Training (HIIT) emerging as a time-efficient, evidence-based approach. This review examines HIIT’s impact on glycemic control, cardiorespiratory fitness, body composition, and inflammation, also addressing safety and feasibility. Methods: A narrative review was conducted via PubMed using terms such as”Type 2 Diabetes, "“glycemia, "“HbA1c, "“physical activity, " and”HIIT." From forty articles screened, nineteen met inclusion criteria. Results and Discussion: HIIT effectively improves T2DM outcomes. It lowers HbA1c, fasting and postprandial glucose, and enhances insulin sensitivity and beta-cell function. Compared to moderate-intensity continuous training (MICT), HIIT often yields superior VO₂max improvements. It also reduces BMI, total and visceral fat, and improves lipid profiles. HIIT is associated with lower inflammatory markers. Implementation is feasible and safe, even for older adults, with high adherence and minimal adverse events. Conclusion: HIIT is a potent non-pharmacological tool in T2DM management, offering benefits across metabolic and cardiovascular domains. Its ability to improve glycemic control, fitness, body composition, and inflammation underscores its clinical relevance. Current evidence supports integrating HIIT into standard care for T2DM patients.